These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 31829429)
1. CRYAB inhibits migration and invasion of bladder cancer cells through the PI3K/AKT and ERK pathways. Ruan H; Li Y; Wang X; Sun B; Fang W; Jiang S; Liang C Jpn J Clin Oncol; 2020 Mar; 50(3):254-260. PubMed ID: 31829429 [TBL] [Abstract][Full Text] [Related]
2. Low expression of PDK1 inhibits renal cell carcinoma cell proliferation, migration, invasion and epithelial mesenchymal transition through inhibition of the PI3K-PDK1-Akt pathway. Zhou WM; Wu GL; Huang J; Li JG; Hao C; He QM; Chen XD; Wang GX; Tu XH Cell Signal; 2019 Apr; 56():1-14. PubMed ID: 30465826 [TBL] [Abstract][Full Text] [Related]
3. Repression of engrailed 2 inhibits the proliferation and invasion of human bladder cancer in vitro and in vivo. Li Y; Liu H; Lai C; Su Z; Heng B; Gao S Oncol Rep; 2015 May; 33(5):2319-30. PubMed ID: 25812440 [TBL] [Abstract][Full Text] [Related]
4. Phospho-Akt pathway activation and inhibition depends on N-cadherin or phospho-EGFR expression in invasive human bladder cancer cell lines. Wallerand H; Cai Y; Wainberg ZA; Garraway I; Lascombe I; Nicolle G; Thiery JP; Bittard H; Radvanyi F; Reiter RR Urol Oncol; 2010; 28(2):180-8. PubMed ID: 19070520 [TBL] [Abstract][Full Text] [Related]
5. N-cadherin promotes thyroid tumorigenesis through modulating major signaling pathways. Da C; Wu K; Yue C; Bai P; Wang R; Wang G; Zhao M; Lv Y; Hou P Oncotarget; 2017 Jan; 8(5):8131-8142. PubMed ID: 28042956 [TBL] [Abstract][Full Text] [Related]
6. CAV-1 contributes to bladder cancer progression by inducing epithelial-to-mesenchymal transition. Liang W; Hao Z; Han JL; Zhu DJ; Jin ZF; Xie WL Urol Oncol; 2014 Aug; 32(6):855-63. PubMed ID: 24968949 [TBL] [Abstract][Full Text] [Related]
7. Tumor suppressor Alpha B-crystallin (CRYAB) associates with the cadherin/catenin adherens junction and impairs NPC progression-associated properties. Huang Z; Cheng Y; Chiu PM; Cheung FM; Nicholls JM; Kwong DL; Lee AW; Zabarovsky ER; Stanbridge EJ; Lung HL; Lung ML Oncogene; 2012 Aug; 31(32):3709-20. PubMed ID: 22158051 [TBL] [Abstract][Full Text] [Related]
8. Overexpression of E74-Like Factor 5 (ELF5) Inhibits Migration and Invasion of Ovarian Cancer Cells. Zhang X; Lin J; Ma Y; Zhao J Med Sci Monit; 2019 Jan; 25():856-865. PubMed ID: 30696803 [TBL] [Abstract][Full Text] [Related]
9. Novel expression of N-cadherin elicits in vitro bladder cell invasion via the Akt signaling pathway. Rieger-Christ KM; Lee P; Zagha R; Kosakowski M; Moinzadeh A; Stoffel J; Ben-Ze'ev A; Libertino JA; Summerhayes IC Oncogene; 2004 Jun; 23(27):4745-53. PubMed ID: 15122336 [TBL] [Abstract][Full Text] [Related]
10. FGFR3 promotes the growth and malignancy of melanoma by influencing EMT and the phosphorylation of ERK, AKT, and EGFR. Li L; Zhang S; Li H; Chou H BMC Cancer; 2019 Oct; 19(1):963. PubMed ID: 31619201 [TBL] [Abstract][Full Text] [Related]
11. MicroRNA-294 Promotes Cellular Proliferation and Motility through the PI3K/AKT and JAK/STAT Pathways by Upregulation of NRAS in Bladder Cancer. Li Y; Shan Z; Liu C; Yang D; Wu J; Men C; Xu Y Biochemistry (Mosc); 2017 Apr; 82(4):474-482. PubMed ID: 28371605 [TBL] [Abstract][Full Text] [Related]
12. Suppression of synuclein gamma inhibits the movability of endometrial carcinoma cells by PI3K/AKT/ERK signaling pathway. Ni M; Zhao Y; Wang X Genes Genomics; 2021 Jun; 43(6):633-641. PubMed ID: 33788083 [TBL] [Abstract][Full Text] [Related]
13. Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells. Wu WL; Wang WY; Yao WQ; Li GD Int J Mol Med; 2015 Dec; 36(6):1713-9. PubMed ID: 26499886 [TBL] [Abstract][Full Text] [Related]
14. HPIP promotes epithelial-mesenchymal transition and cisplatin resistance in ovarian cancer cells through PI3K/AKT pathway activation. Bugide S; Gonugunta VK; Penugurti V; Malisetty VL; Vadlamudi RK; Manavathi B Cell Oncol (Dordr); 2017 Apr; 40(2):133-144. PubMed ID: 28039608 [TBL] [Abstract][Full Text] [Related]
15. Danusertib, a potent pan-Aurora kinase and ABL kinase inhibitor, induces cell cycle arrest and programmed cell death and inhibits epithelial to mesenchymal transition involving the PI3K/Akt/mTOR-mediated signaling pathway in human gastric cancer AGS and NCI-N78 cells. Yuan CX; Zhou ZW; Yang YX; He ZX; Zhang X; Wang D; Yang T; Pan SY; Chen XW; Zhou SF Drug Des Devel Ther; 2015; 9():1293-318. PubMed ID: 25767376 [TBL] [Abstract][Full Text] [Related]
16. Alpha B-crystallin promotes the invasion and metastasis of colorectal cancer via epithelial-mesenchymal transition. Shi C; Yang X; Bu X; Hou N; Chen P Biochem Biophys Res Commun; 2017 Aug; 489(4):369-374. PubMed ID: 28506831 [TBL] [Abstract][Full Text] [Related]
17. PI3K/Akt to GSK3β/β-catenin signaling cascade coordinates cell colonization for bladder cancer bone metastasis through regulating ZEB1 transcription. Wu K; Fan J; Zhang L; Ning Z; Zeng J; Zhou J; Li L; Chen Y; Zhang T; Wang X; Hsieh JT; He D Cell Signal; 2012 Dec; 24(12):2273-82. PubMed ID: 22906492 [TBL] [Abstract][Full Text] [Related]
18. WSTF promotes proliferation and invasion of lung cancer cells by inducing EMT via PI3K/Akt and IL-6/STAT3 signaling pathways. Meng J; Zhang XT; Liu XL; Fan L; Li C; Sun Y; Liang XH; Wang JB; Mei QB; Zhang F; Zhang T Cell Signal; 2016 Nov; 28(11):1673-82. PubMed ID: 27449264 [TBL] [Abstract][Full Text] [Related]
19. Successive treatment with naltrexone induces epithelial-mesenchymal transition and facilitates the malignant biological behaviors of bladder cancer cells. Wang X; Zhang R; Wu T; Shi Y; Zhou X; Tang D; Yu W; So EC; Wu X; Pan Z; Tian J Acta Biochim Biophys Sin (Shanghai); 2021 Feb; 53(2):238-248. PubMed ID: 33410473 [TBL] [Abstract][Full Text] [Related]
20. F-box protein FBXO31 modulates apoptosis and epithelial-mesenchymal transition of cervical cancer via inactivation of the PI3K/AKT-mediated MDM2/p53 axis. Liu K; Xue B; Bai G; Zhang W Life Sci; 2020 Oct; 259():118277. PubMed ID: 32800832 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]